| 000 | 01530 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517025004.0 | ||
| 264 | 0 | _c20161214 | |
| 008 | 201612s 0 0 ger d | ||
| 022 | _a1432-2129 | ||
| 024 | 7 |
_a10.1007/s00482-014-1499-y _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKoy, S | |
| 245 | 0 | 0 |
_a[Bisphosphonate-associated osteonecrosis of the jaw]. _h[electronic resource] |
| 260 |
_bSchmerz (Berlin, Germany) _cApr 2015 |
||
| 300 |
_a171-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBisphosphonate-Associated Osteonecrosis of the Jaw _xdiagnosis |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aDiphosphonates _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xadverse effects |
| 650 | 0 | 4 | _aInterdisciplinary Communication |
| 650 | 0 | 4 | _aIntersectoral Collaboration |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aOsteoporosis _xdrug therapy |
| 650 | 0 | 4 |
_aPlasmacytoma _xdrug therapy |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTooth Extraction |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aZoledronic Acid |
| 700 | 1 | _aSchubert, M | |
| 700 | 1 | _aKoy, J | |
| 700 | 1 | _aNey, M | |
| 700 | 1 | _aLauer, G | |
| 700 | 1 | _aSabatowski, R | |
| 773 | 0 |
_tSchmerz (Berlin, Germany) _gvol. 29 _gno. 2 _gp. 171-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00482-014-1499-y _zAvailable from publisher's website |
| 999 |
_c24791279 _d24791279 |
||